Navigation Links
Kent State University Stark Campus to Confer First Class of Nursing Students
Date:4/14/2008

JACKSON TOWNSHIP, Ohio, April 14 /PRNewswire-USNewswire/ -- "When I began teaching at the Stark Campus, I knew that nursing should be offered as a four-year program," says Kathryn Cartechine, assistant professor of nursing at Kent State University Stark Campus in North Canton, Ohio.

In 2006, the largest Regional Campus of Kent State University expanded its four-year degree programs to allow students to earn their bachelor's in nursing, making it one of the 11 undergraduate programs offered by the campus. In May, the first graduates to have taken all of their courses at the Stark Campus will proudly walk across the stage to receive their diplomas.

Among those will be Shellee Wandel, a student who feels that the faculty and instruction she received at Kent State Stark will be a strong foundation for her future career in nursing. "I believe I am fully prepared," she says. "Our instructors are amazing resources. They're currently working in the same fields that they're teaching, so they are able to train us on the latest treatments and methods."

Cartechine spoke of the nursing faculty's knowledge and expertise. "Each is an expert in a specialty area in which students have interest, giving them the ability to mentor them in a specific field of study."

Another soon-to-be graduate is Susan Tortora, who began college at the Kent Campus, but transferred to the Stark Campus to complete the nursing program. "I'm glad I decided to come here," says Tortora. "This campus is really big on student-teacher interaction. The faculty are a strong network of support. They go the extra mile by getting to know the students, becoming familiar with our work ethics, even giving us their cell phone numbers. They're that accessible."

Wandel agreed with Tortora, saying that the faculty ensures student success by helping them when they notice a problem. "If you get a bad test score, that instructor is going to seek you out to figure out what we
'/>"/>

SOURCE Kent State University Stark Campus
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Exercise may lead to faster prostate tumor growth
2. UMDF Statement on the Connection Between Mitochondrial Disease and Autism
3. April 15 is Deadline for Input on State Aging Plan
4. 3T MRI plays significant role in detecting prostate cancer, study says
5. National Healthcare Decisions Day in All 50 States, DC, Puerto Rico, and Internationally
6. Iowa State University researcher looks to use nanoparticles for food safety
7. Open Letter to Presidential Candidates on State Health Care Reform
8. Massachusetts Affiliate of Susan G. Komen for the Cure(R) to Challenge States Leaders to Strengthen Breast Cancer Services
9. CamelBak(R) CEO Statement on BPA and Plastic Re-Usable Water Bottles
10. Statement by the American Egg Board and Egg Nutrition Center on AJCN Study on Egg Consumption
11. Paro, the Baby Seal Service Robot From Japan, Finds a New Home in the United States With Help From JETRO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...on January 8, 2009 , , TORONTO, Nov. 21 /PR... ("MedEmerg") (OTCBB: MDER), one of Canada,s leadi...hat it has obtained an interim order from the Onta...ously announced plan of arrangement (the "Arrangem...M") will acquire all of MedEmerg,s outstanding sha...
(Date:11/21/2008)...l/ -- The Providence Service,Corporation (Nasdaq:...e Company,s,Chief Operating Officer, has been app...Norris, appointment fills the vacancy left by the ...returns the board to six members. Mr.,Norris wil... Mr. Norris, age 41, has been with Providence sin...
(Date:11/21/2008)... The University of Texas M. D. Anderson Cancer C...rt to eradicate breast cancer in Panama through th...arch of the Americas today at an event with Laura ...ian Fernandez de Torrijos, the First Lady of Panam...tive are the U.S. Department of State and Susan G....
(Date:11/21/2008)...al membership of the Medical,Advertising Hall of ...r Annual,Awards Dinner to be held February 10, 20...hievement Award will also be given. , The 2... Fame are: , Ronald Pantello, who began his adv...r & Hennessey. In 1980 he left Sudler & He...
Breaking Medicine News(10 mins):Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 2Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 3Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 3Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 2Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 3
...utionary weapon for the war against the bulges and...tates. Alli- a fat blocker is the first FDA appro...ithout a prescription. The prescription diet drug ...store shelves with a new name and in nonprescripti...
...o Springs community of U.S is waiting with bated b...e if any person has contracted TB from a young nu...to health officials, tuberculosis has been found r...a Dangol, a young Nepalese student at Colorado Sp...
...that men spends more waking time thinking about...subject in equal measure once the lights are out. ...ecades, the canadian research team report that abo...am reports from both genders contain some form of ...
... at the La Jolla Institute for Allergy & Immunolog...entually lead to a new therapeutic approach for tr...as rheumatoid arthritis, colitis, psoriasis and ot...atory mice, demonstrated the role of retinoic acid...
Other Medicine News:Health News:Alli- a New Weapon for War Against the Bulges 2Health News:Fears Of Spread Of TB After Students Death 2Health News:Equality Among Genders in Terms of Sex Dreams 2Health News:New Therapeutic Approach for Autoimmune and Inflammatory Diseases 2
(Date:11/20/2008)...November 20 Arpida (SWX:...ugs Advisory Committee of the,U.S. Food and Drug ...,approval of intravenous iclaprim, an antibiotic ...ients with complicated skin and skin structure inf...cillin-resistant Staphylococcus,aureus (MRSA). ,...
(Date:11/20/2008)...0 Bionovo, Inc.,(Nasdaq...lts from the Phase 1B,clinical trial of their lea...ancer, BZL101, at the Society for Integrative Onco... Georgia. The Company,s oral presentation was sel...nted as a part of the Best of the,SIO Session on ...
(Date:11/20/2008)... Radius Health ("Radius") announced...n to its second institutional financing round, inc... and the total amount raised since the company,s i...onal investors participated in the financing, led ... Capital, The Wellcome Trust, HealthCare Ventures,...
(Date:11/20/2008)...e-FirstCall/ -- PAREXEL International Corporation ...cal services provider, today announced that it has...ory consulting and clinical research capabilities.... has locations throughout five important biopharma...ude Argentina, Brazil, Chile, and Mexico. This exp...
Breaking Medicine Technology:Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Emageon Receives Best in KLAS Cardiology PACS Award 15216 1Emageon Receives Best in KLAS Cardiology PACS Award 15216 2QMed Inc Reports Year End and Fourth Quarter Results 15213 1QMed Inc Reports Year End and Fourth Quarter Results 15213 2QMed Inc Reports Year End and Fourth Quarter Results 15213 3QMed Inc Reports Year End and Fourth Quarter Results 15213 4QMed Inc Reports Year End and Fourth Quarter Results 15213 5QMed Inc Reports Year End and Fourth Quarter Results 15213 6QMed Inc Reports Year End and Fourth Quarter Results 15213 7Best Practice Database 3A Complimentary Excerpt of Scientific Publications Strategy Study 15210 1Best Practice Database 3A Complimentary Excerpt of Scientific Publications Strategy Study 15210 2NCPA Statement on Californias Delay of E Pedigree Implementation 15207 1NCPA Statement on Californias Delay of E Pedigree Implementation 15207 2
...ase History Highlighted in AACR Cancer Journal , A...gen,Therapeutics, Inc. (NASDAQ:INGN) announced tod... clinical benefit of its lead product,Advexin in a...n as,Li-Fraumeni Syndrome (LFS), a genetic disorde...tumor suppressor gene. This is the,first reported ...
...SLO, Norway, 30 May 2007 - Algeta ASA (OSE: ALGETA...unces that Professor,Øyvind Bruland, of the...geta, will present a Poster and Discussion entitle...one refractory,prostate cancer (HRPC): Results fro...," at the American Society of,Clinical Oncology,s ...
Other Medicine Technology:Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 2Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 3Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 4Algeta to Present Phase II Clinical Study Data for Alpharadin in,Prostate Cancer at ASCO 2
3 mm, 130 degree upwards cutting, detachable.
Sabre 180 is a powerful niche generator.
The Sabre 2400 provides high power performance and key user features to meet today's demanding electrosurgical needs. It is an ideal general-purpose electrosurgical generator.
The ExcaliburPlus PC is the most powerful isolated ESU with 10,000 V PTP in spray coag.
Medicine Products: